Dr. SlevinCURRICULUM VITAE

DONALD J. SLEVIN, M.D.

EDUCATION

June 1969 - June 1973 B.S., Cum Laude Tufts University
Medford, Massachusetts

June 1973 - June 1977 M.D. University of Health Science
Chicago Medical School
Chicago, Illinois

June 1977 - June 1978 Internship Maricopa Medical Center
General Surgery Phoenix, Arizona

June 1978 - June 1979 Residency PGY - 2 Maricopa Medical Center
General Surgery Phoenix, Arizona

June 1979 - August 1982 Residency PGY 3-4-5 Phoenix Integrated
Orthopedic Surgery Orthopedic Program
Phoenix, Arizona

August - November 1982 Fellowship Edward D. Campbell, M.D.
Arthroscopic Surgery St. Luke's Hospital
Phoenix, Arizona

EMPLOYMENT

1982 Present Sarasota Orthopedic Associates, Sarasota, FL
Private Practice - Emphasis on Sports Medicine, Arthroscopy, Knee
And Shoulder Disorders

1984 Team Physician, Sarasota Stingers
(Professional CBA Basketball Team)

1988 - 1999 Team Physician, Spring Training and Minor League Chicago White Sox

1990 - 1994 Team Physician, Booker High School

1990 - Present Team Physician, Sarasota High School

2001 - Present Team Physician, Sarasota Scullers

2002 Event Physician USTA Sarasota Open Tennis Tournament

2002 - 2003 Team Physician Baltimore Orioles

2003 Gomez Tennis Academy - Team Physician

2004 Celsius Tennis Academy - Team Physician

FELLOW

American Academy of Orthopedic Surgeons - Induction January 1988

DIPLOMATE

National Board of Medical Examiners July 1978
American Board of Orthopedic Surgeons July 1985

LICENSURE

Florida State Board of Medical Examiners - License #ME 40667

AWARDS AND HONORS

1972 Qualified Olympic Trials, Eugene, Oregon

1973 All American Collegiate Track and Field Team

IX World Macabiah High Hurdles Champion
Tel Aviv, Israel

Alex Elias Scholar Athlete Award
Tufts University

1983, 1989 Chief, Orthopedic Sub-Section, Sarasota Memorial Hospital
Sarasota, Florida

REFERENCES BY REQUEST

PUBLICATIONS

"Arthroscopy and its Place in Arthritis Therapy" Chapter in Rehabilitation Management of
Rheumatic Conditions, Williams and Wilkins, Published 1985.

Rendell, Slevin, et al. "A Case of Maturity Onset Diabetes Mellitus Resistant to Insulin but
Sensitive to Tolbutamide" Annals of Internal Medicine, Vol. 90, No. 2, February 1979.

PAPERS AND LECTURES READ AT MEETINGS

Slevin, Donald J. "Clinical Evaluation of the Shoulder" Annual Meeting of National
Athletic Trainers Association. June 1996, Orlando, Florida

Slevin, Donald J. "Advances in Knee Surgery" Florida Association of Orthotists and
Prosthetists, 1994, Orlando, Florida

Slevin, Donald J. "Intramedullary Fracture Fixation" Read at Meeting of Florida Chapter
AORN, Venice, Florida, February 1984

Slevin, Donald J. "Arthroscopy and its Place in the Treatment of Arthritis" Read at
American Arthritis Foundations S. W. Florida Chapter Meeting, Venice, Florida, October 1983

Slevin, Donald J. "Treatment of Patellofemoral Disorders in Patients Under 30" Read at Arizona Chapter Western Orthopedic Association, April 1982

Slevin, Donald J. "Scoliosis in Myelodysplasia” Read at the Spring Symposium, Arizona
Children's Hospital, Arizona Chapter Western Orthopedic Association, April 1981

Slevin, Donald J. "Failed Total Hip Replacement Requiring Re-operation" Read at Fall Lectureship – Total Joint Update, Phoenix, Arizona, October 1981

Slevin, Donald J. "Treatment of Pit Viper Snakebites" Read at the Fall Symposium, Arizona Chapter Western Orthopedic Association, 1980

Slevin, Donald J. "Acute Hematogenous Osteomyelitis" Read at the Fall Symposium, Arizona Children's Hospital, April 1980

RESEARCH EXPERIENCE

Phase 3, Randomized, Double-Blind, Fixed Dose, Parallel-Group, Comparison of Controlled-Release XXX XXX (XXX) vs. Placebo in Subjects with Osteoarthritis. Sub-Investigator; Walter K. Furman, Principal Investigator. October 2004 to present.

Phase III, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and the Safety of XXX on the Rate of Healing in Distal Radius Fractures. Sub-Investigator; David Klein, Principal Investigator. March 2004 to September 2004.

Phase IIb Dose-ranging trial of Oral Direct Factor Xa Inhibitor XXX in the Prevention of VTE in Patients Undergoing Total Knee Replacement, ODiXaKnee. Sub-Investigator; Walter K. Furman, MD, Principal Investigator, February 2004 to present.

Phase IV, flexibility in administration of XXX for prevention of symptomatic venous thromboembolism in orthopedic surgery. Sub-Investigator; Walter K. Furman, MD, Principal Investigator, August 2003 to January 2004.

RE-MOBILIZE. A Phase III Randomized, Parallel-Group, Double-Blind, Active Controlled Study to Investigate the Efficacy and Safety of Two Different Dose Regimens (75mg Day 1 Followed by 150mg Day 2 - Completion, and 110mg Day 1 Followed by 220mg Day 2 - Completion) of XXX Administered Orally (Capsules), Compared to XXX 30mg Twice a Day Subcutaneous for 12-15 Days, in Prevention of Venous Thromboembolism in Patients with Primary Elective Total Knee Replacement Surgery